A PE-backed medical technology company in Oxford specialising in organ preservation has completed a $142m primary and secondary equity financing.

OrganOx, a British developer of technologies to maintain organs for transplant, raised $142m in primary and secondary funding ...

OrganOx 's metra normothermic machine perfusion platform gained approval in Australia, Europe, Canada, and the US.

OrganOx announced today that it completed a $142 million primary and secondary equity financing to accelerate growth opportunities.

Financing strengthens OrganOx to expand its leadership position in organ technologyOXFORD, United Kingdom and MADISON, N.J., Feb. 24, 2025., a leading organ medical technology company, successfully co ...

OrganOx, with its system for actively preserving viable donor tissue ahead of a transplant procedure, has raised $142 million ...

Proper management of working capital is essential to a company’s fundamental financial health and operational success as a business. A hallmark of good business management is the ability to ...

Alphabet has gained about 9% so far this year. Wall Street had been expecting 2025 capital expenditures of about $58 billion, according to LSEG data. That would have marked a modest increase over ...

RICHMOND, Va. — The Capital Area Health Network has closed three of its medical centers in the Richmond area, citing unforeseen federal restrictions as the cause. The closures, which include the ...

The strategies approved by the Federal Executive Council (FEC) at its meeting in Abuja include a $1 billion initiative to strengthen human capital development and N4.8 billion for the Presidential ...